Clinical evaluation of incadronate in korean patients with malignancy-associated hypercalcemia: An open-label, multicenter study

Abstract BACKGROUND: Incadronate has been found to lessen the increase in corrected serum calcium levels in malignancy-associated hypercalcemia (MAH) in a Phase III study in Japan. The drug is currently used to treat MAH in Japan. OBJECTIVE: The purpose of this study was to assess the clinical usefu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Sung-Bae, Lee, Jung Shin, Kim, Heung Tae, Im, Yong Hyuck, Kim, Tae Won, Ryoo, Baek Yeol, Park, Yeon Hee, Park, Joon Oh, Park, Keunchil, Katoh, Hitoshi, Yamamoto, Minoru
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2007
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3967285/
https://ncbi.nlm.nih.gov/pubmed/24683210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2007.06.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars